Document Detail

Thrombocytopenia in preeclampsia and eclampsia.
MedLine Citation:
PMID:  6813969     Owner:  NLM     Status:  MEDLINE    
1. The lack of a general agreement on the definition of PE makes the interpretation of laboratory findings in different series of these patients difficult. 2. Thrombocytopenia is the most common hemostatic abnormality in patients with PE and is caused by platelet consumption. 3. There is little concrete evidence that thrombin mediates the thrombocytopenia in most of these patients. 4. Immune mechanisms or severe vasospasm with resultant endothelial damage may contribute to the thrombocytopenia in some patients.
B Gibson; D Hunter; P B Neame; J G Kelton
Related Documents :
2382189 - Predicting failure of low-dose prophylactic heparin in general surgical procedures.
9923779 - The prevalence of factor v leiden mutation in patients with leg ulcers and venous insuf...
20954129 - Endovascular intervention for central venous cannulation in patients with vascular occl...
1495139 - Photoplethysmography: a valuable noninvasive tool in the assessment of venous dysfunction?
15389909 - Home prothrombin time monitoring: a literature analysis.
10634159 - Coagulation abnormalities in idiopathic portal venous thrombosis.
22865239 - Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from ...
6648499 - The prevalence of gastrinomas in recurrent peptic ulceration.
11738099 - Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Seminars in thrombosis and hemostasis     Volume:  8     ISSN:  0094-6176     ISO Abbreviation:  Semin. Thromb. Hemost.     Publication Date:  1982 Jul 
Date Detail:
Created Date:  1982-12-16     Completed Date:  1982-12-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0431155     Medline TA:  Semin Thromb Hemost     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  234-47     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia, Hemolytic / blood,  complications
Disseminated Intravascular Coagulation / blood,  complications
Eclampsia / blood*
Epoprostenol / biosynthesis
Factor VIII / biosynthesis
Fibrin / metabolism
Fibrin Fibrinogen Degradation Products / analysis
Fibrinogen / analysis
Fibrinopeptide A / biosynthesis
Hypertension / complications
Platelet Count
Pre-Eclampsia / blood*,  complications,  pathology
Pregnancy Complications, Hematologic / blood*
Thrombin / metabolism
Thrombocytopenia / blood*,  complications
Thromboxane A2 / biosynthesis
Reg. No./Substance:
0/Fibrin Fibrinogen Degradation Products; 0/fibrinmonomer; 25422-31-5/Fibrinopeptide A; 35121-78-9/Epoprostenol; 57576-52-0/Thromboxane A2; 9001-27-8/Factor VIII; 9001-31-4/Fibrin; 9001-32-5/Fibrinogen; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neuromagnetic localization of epileptiform spike activity in the human brain.
Next Document:  Breast cancer screening. A study in cost-effectiveness analysis.